Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189701 | Brachytherapy | 2013 | 5 Pages |
Abstract
Our study shows that the HDR contribution is 7% (4.00Â Gy) of the total EQD2 (57.45Â Gy). The HDR contribution should be accounted for when prescribing the EBRT boost dose to pelvic LNs for the optimal therapeutic dose.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yongsook C. Lee, Dominique L. Rash, Robin L. Stern, Jyoti S. Mayadev,